Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion type Assertion NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_head.
- NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion description "[The molecular pathways involved in the aetiology of these syndromes have recently been more clearly defined and several major cellular signalling pathways are probably involved: the protein kinase A (PKA) pathway in Carney complex (CNC), the Ras/Erk MAP kinase pathway in LEOPARD/Noonan syndromes, and the mammalian target of rapamycin pathway (mTOR) in Peutz-Jeghers syndrome and the diseases caused by PTEN mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_provenance.
- NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion evidence source_evidence_literature NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_provenance.
- NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion SIO_000772 15958502 NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_provenance.
- NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion wasDerivedFrom befree-20140225 NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_provenance.
- NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_assertion wasGeneratedBy ECO_0000203 NP704316.RAuBUB1Sv-HsVBNVPlSppgiTtI1-YGDHAD3WLuUYm-cZU130_provenance.